Morocco Seeks to Boost Tourism in Western Sahara Amid Sovereignty Dispute
SpaceX Scrub of Starship Test Flight Delays Debut of NextGeneration Rocket
Niva Bupa Aims to Secure Top Two Retail Health Insurance Position Within Three Years
Investors Flock to HALO Stocks A New ETF Captures the AIProof Theme
Gift Nifty Signals Strong Start for Indian Equities as Global Sentiment Improves Over Weekend
Vickers Insider Trading Report Top Buyers and Sellers for May 28 2026
Enveric Biosciences Inc ENVB Q4 2024 Earnings Massive EPS Miss Highlights Ongoing Cash Burn and No Revenue
NRG Q1 2026 Earnings EPS Misses Expectations Amid Mixed Performance
CGBD Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance
RKLB Q1 2026 Earnings EPS Beats Estimates as Rocket Lab Narrows Losses
NewMarket Corp NEU Q1 2026 Earnings Robust EPS Performance Drives Positive Market Response
Bone Biologics Corp BBLG Q1 2026 Earnings Narrower Loss Beats Estimates Shares Dip
Data IO Corporation DAIO Navigates Technical Crossroads After Modest Decline
Pitney Bowes Faces Resistance as Selling Pressure Intensifies
KT Corporation KT Faces Downward Pressure as Shares Decline 137
CVRx Inc CVRX Stabilizes Above 6 Support Resistance Test Ahead
Blueport Acquisition Rights BPACR Edges Higher as Speculative Trading Volume Picks Up
Nvidia Posts Record Earnings But Shares Dip as Growth Concerns Mount
PMTU Q1 2026 Earnings Significant EPS Miss as Mortgage Market Pressures Persist
Artivion Inc AORT Faces Selling Pressure as Shares Dip Below Key Moving Averages
PSX Q1 2026 Earnings EPS Surges Past Estimates Driven by Operational Strength
PLAY Q1 2026 Earnings Major EPS Miss Clouds Outlook Stock Inches Higher
CDIO Q1 2025 Earnings Narrowerthanexpected loss surprises market
BCRX Q1 2026 Earnings EPS Misses Estimates Stock Rises on Operational Updates
GTES Q1 2026 Earnings EPS Beats Estimates by 47 Shares Edge Higher
Armata Pharmaceuticals Q1 2026 Earnings Significant EPS Miss but Stock Rises on Pipeline Progress
ICCM Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development